Letter: impact of hepatitis B core‐related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analogues—further clarifications needed

Letter: impact of hepatitis B core‐related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analogues—further clarifications needed

Linked ContentThis article is linked to Hosaka et al and Hosaka papers. To view these articles, visit https://doi.org/10.1111/apt.15108. https://doi.org/10.1111/apt.15332 and https://doi.org/10.1111/apt.15361.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alimentary pharmacology & therapeutics 2019-07, Vol.50 (2), p.232-232
Hauptverfasser: Lim, Miao‐Shan, Tan, Chee‐Kiat
Format: Artikel
Sprache:eng
Schlagworte:
Carcinoma, Hepatocellular
Hepatitis
Hepatitis B
Hepatitis B Core Antigens
Hepatitis B, Chronic
Hepatocellular carcinoma
Humans
Incidence
Liver Neoplasms
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Linked ContentThis article is linked to Hosaka et al and Hosaka papers. To view these articles, visit https://doi.org/10.1111/apt.15108. https://doi.org/10.1111/apt.15332 and https://doi.org/10.1111/apt.15361.
ISSN:0269-2813
1365-2036
DOI:10.1111/apt.15254